The elderly suffer more serious complications from infections and benefit less from vaccination than the general population. Scientists have long known that a weakened immune system is to blame but the exact mechanisms behind this lagging immunity have remained largely unknown.
Now research led by investigators at Harvard Medical School suggests that weakened metabolism of immune T cells may be partly to blame.
The findings, published Dec. 10 in PNAS and based on experiments in mouse immune cells, pinpoint a specific metabolic pathway called one-carbon metabolism that is deficient in the aged T cells of rodents. The work also suggests possible ways to restore weakened immune function with the use of small-molecule compounds that boost T cell performance.
"We believe our findings may help explain the basic malfunction that drives loss of immune defenses with age," said senior study author Marcia Haigis, professor of cell biology in the Blavatnik Institute at Harvard Medical School. "If affirmed in further studies, we hope that our findings can set the stage for the development of therapies to improve immune function."
The role of T cells in the immune system is twofold: attacking illness-causing cells like bacteria, viruses and cancer and "remembering" past invaders--the body's way of ensuring that it can spot a threat and mount a rapid defense during subsequent encounters with the same pathogens. In a healthy person, T cells circulate in the blood and quietly scan the body for threats using proteins on the cell's surface. If a T cell encounters another cell it deems dangerous, the T cell undergoes activation, a molecular cascade in which it switches from surveillance mode to attack mode. The activated cells then rapidly replicate to build an army and destroy the enemy.
First, the researchers looked for overall differences between old and young T cells. They isolated T cells from the spleens of young and old mice and noticed that, in general, older mice had fewer T cells. Next, to gauge the cells' immune fitness, the researchers activated the T cells by mimicking signals normally turned on by pathogens during infection. The older T cells showed diminished activation and overall function in response to these alarm signals. Specifically, they grew more slowly, secreted fewer immune-signaling molecules and died at a much faster rate than young T cells. The researchers also observed that aged T cells had lower metabolism, consumed less oxygen and broke down sugars less efficiently. They also had smaller than normal mitochondria, the cells' power-generators that keep them alive.
It was as if these older immune cells had lost their "appetite" and their ability to process fuel into energy, Haigis and her colleagues observed.
To pinpoint the metabolic pathways behind this malfunction, the scientists analyzed all the different proteins in the cells, including those that might be important for coaxing a T cell from dormancy into a fighting state. The team found that the levels of some 150 proteins were lower-than-normal upon activation of the aged T cells, compared with young T cells. About 40 proteins showed higher than normal levels in aged versus young T cells. Many of these proteins have unknown functions, but the researchers found that proteins involved a specific type of metabolism, called one-carbon metabolism, were reduced by nearly 35 percent in aged T cells.
One-carbon metabolism comprises a set of chemical reactions that take place in the cell's mitochondria and the cell cytosol to produce amino acids and nucleotides, the building blocks of proteins and DNA. This process is critical for cellular replication because it supplies the biologic material for building new cells.
The team's previous work had shown that one-carbon metabolism plays a central role in supplying essential biological building blocks for the growing army of T cells during infection. So, the scientists wondered, could adding the products of this pathway to weakened T cells restore their fitness and function?
To test this hypothesis, the team added two molecules--formate and glycine, the main products of one-carbon metabolism--whose levels were markedly reduced in aged T cells. Indeed, adding the molecules boosted T cell proliferation and reduced cell death to normal levels.
The researchers caution that while encouraging, the effects were observed solely in mouse cells in lab dishes rather than in animals and must be confirmed in further experiments.
Additional authors on the study included Noga Ron-Harel, Giulia Notarangelo, Jonathan Ghergurovich, Joao Paulo, Peter Sage, Daniel Santos, F. Kyle Satterstrom, Steven Gygi, Joshua Rabinowitz and Arlene Sharpe.
This work was supported by grants from F. Hoffmann-La Roche, the Glenn Foundation for Medical Research, National Institutes of Health (grant R01CA213062), a postdoctoral fellowship from the EMBO (European Molecular Biology Organization) and by the Israeli National Postdoctoral Award Program for Advancing Women In Science.
About Harvard Medical School
Harvard Medical School has more than 11,000 faculty working in the 11 basic and social science departments comprising the Blavatnik Institute and at the 15 Harvard-affiliated teaching hospitals and research institutes: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Cambridge Health Alliance, Dana-Farber Cancer Institute, Harvard Pilgrim Health Care Institute, Hebrew SeniorLife, Joslin Diabetes Center, Judge Baker Children's Center, Massachusetts Eye and Ear/Schepens Eye Research Institute, Massachusetts General Hospital, McLean Hospital, Mount Auburn Hospital, Spaulding Rehabilitation Network and VA Boston Healthcare System.